LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) Accounts Payable

As of the most recent data (March 2025), LSBPW shows a accounts payable of $50M. That compares with $68M in the prior-year period — down 26.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, LSBPW's accounts payable is now $50M (was $68M) — a 26.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) is outperforming or lagging.

Tracking LSBPW's accounts payable over time shows whether LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) is scaling, shrinking, or reshaping that part of the business. The current reading is $50M That compares with $68M in the prior-year period — down 26.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has LakeShore Biopharma Co Ltd. - Warrants (15/03/2028)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $50M) with ownership activity and broader fundamentals.